AngioDynamics

AlphaVac And NanoKnife Will Transform Global Minimally Invasive Care

AnalystHighTarget

Not Invested

Consensus Narrative from 4 Analysts

Published

04 Sep 25

AnalystHighTarget's Fair Value

US$24.00

55.3% undervalued

04 Sep

US$10.73

49.7%

4.6%

49.7%

4.6%

Edit anytime before Sep 4 9:33 PM. Then post Updates to your followers.

Author's Valuation

US$24.0

55.3% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$24.0

55.3% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

6.45%

Medical Equipment revenue growth rate

0.43%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.43%

Calculation

US$12.20m

Earnings '28

97.80x

PE Ratio '28

US$1.19b

Market Cap '28

US$1.19b

Market Cap '28

40.63m

No. shares '28

US$29.36

Share Price '28

US$29.36 Share Price '28

Discounted to 2025 @ 7.51% p.a.

US$23.63

Fair Value '25